Viewing Study NCT04540861


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-01-19 @ 3:05 AM
Study NCT ID: NCT04540861
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2025-12-04
First Post: 2020-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module